Conecte-se

Bibliografias temáticas / United States. Advisory Committee on Immunization Practices / Artigos de revistas

Artigos de revistas sobre o tema "United States. Advisory Committee on Immunization Practices"

Siga este link para ver outros tipos de publicações sobre o tema: United States. Advisory Committee on Immunization Practices.

Autor: Grafiati

Publicado: 25 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "United States. Advisory Committee on Immunization Practices".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

O’Leary, Sean T., Yvonne A. Maldonado e David W. Kimberlin. "Update from the Advisory Committee on Immunization Practices". Journal of the Pediatric Infectious Diseases Society 9, n.º 1 (4 de fevereiro de 2020): 3–5. http://dx.doi.org/10.1093/jpids/piaa008.

Texto completo da fonte

Resumo:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. There are usually 15 voting members; members’ terms are for 4 years. ACIP members and Centers for Disease Control and Prevention staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and results from clinical trials. Representatives from the American Academy of Pediatrics (Y. A. M., D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met on 23–24 October 2019 to discuss pertussis vaccines, the child/adolescent and adult immunization schedule, influenza vaccine effectiveness and safety, Ebola vaccine, orthopoxvirus vaccines, Dengue vaccine, rabies vaccine, measles, and vaccine safety update.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Hall, Caroline Breese. "The Recommended Childhood Immunization Schedule of the United States". Pediatrics 95, n.º 1 (1 de janeiro de 1995): 135–37. http://dx.doi.org/10.1542/peds.95.1.135.

Texto completo da fonte

Resumo:

The complexity of our current schedule for routine immunization of children is expanding and experienced by both physician and parent. Over nearly two decades in the 1970s and 1980s only one new vaccine was added to the routine immunization for children. However, in the last few years since 1989, the schedule routinely recommended for children has been augmented by eight to ten new doses or vaccines. The confusion has been compounded by differences in the schedules developed by the American Academy of Pediatrics' (AAP) Committee on Infectious Diseases and that of the Centers for Disease Control Advisory Committee on Immunization Practices (ACIP).

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

O’Leary, Sean T., Yvonne A. Maldonado e David W. Kimberlin. "Update From the Advisory Committee on Immunization Practices". Journal of the Pediatric Infectious Diseases Society 8, n.º 5 (1 de agosto de 2019): 379–83. http://dx.doi.org/10.1093/jpids/piz045.

Texto completo da fonte

Resumo:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. The group usually has 15 voting members, each of whom is appointed to a 4-year term. ACIP members and Centers for Disease Control and Prevention staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (Y. A. M. and D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met February 27 to 28, 2019, to discuss hepatitis A (HepA) vaccination of human immunodeficiency virus–infected persons, pneumococcal vaccination among adults aged 65 years or older, influenza vaccine effectiveness and safety, anthrax vaccination in the setting of a mass exposure, human papillomavirus vaccine, zoster vaccines, and Japanese encephalitis vaccine.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

O’leary, Sean T., Yvonne A. Maldonado e David W. Kimberlin. "Update From the Advisory Committee on Immunization Practices". Journal of the Pediatric Infectious Diseases Society 8, n.º 6 (7 de outubro de 2019): 495–500. http://dx.doi.org/10.1093/jpids/piz058.

Texto completo da fonte

Resumo:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. There usually are 15 voting members, but at the June 2019 meeting, only 14 were present; each member’s term is 4 years. ACIP members and Centers for Disease Control and Prevention (CDC) staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (AAP) (Y. A. M. and D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met on June 26 to 27, 2019, to discuss the use of human papillomavirus (HPV) vaccine in adults, pneumococcal vaccines in adults, measles updates, zoster vaccine, influenza vaccines, hepatitis A virus (HAV) vaccines, meningococcal vaccines, and dengue vaccine.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Walton, L. Reed, Walter A. Orenstein e Larry K. Pickering. "The history of the United States Advisory Committee on Immunization Practices (ACIP)". Vaccine 33, n.º 3 (janeiro de 2015): 405–14. http://dx.doi.org/10.1016/j.vaccine.2014.09.043.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Pau, Alice K., Ian R. McNicholl e Kenneth J. Pursell. "Active Immunization in HIV‐infected Patients". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16, n.º 2 (4 de março de 1996): 163–70. http://dx.doi.org/10.1002/j.1875-9114.1996.tb02934.x.

Texto completo da fonte

Resumo:

Patients infected with human immunodeficiency virus (HIV) are at risk for various viral and bacterial infections. Active immunization with currently available vaccines may reduce the risk of some vaccine‐preventable diseases in this population. Based on available data, most vaccines used in the United States are safe in HIV‐infected adults and children. Their clinical efficacy in these individuals is not well defined, although it appears that patients in the earlier stages of infection are more likely to mount a protective antibody response than those in the later stages. Current guidelines for vaccination in HIV‐infected children and adults in the United States have been recommended by the Advisory Committee on Immunization Practices.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Paz-Bailey, Gabriela, Laura Adams, Joshua M. Wong, Katherine A. Poehling, Wilbur H. Chen, Veronica McNally, Robert L. Atmar e Stephen H. Waterman. "Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021". MMWR. Recommendations and Reports 70, n.º 6 (17 de dezembro de 2021): 1–16. http://dx.doi.org/10.15585/mmwr.rr7006a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Mbaeyi, Sarah A., Catherine H. Bozio, Jonathan Duffy, Lorry G. Rubin, Susan Hariri, David S. Stephens e Jessica R. MacNeil. "Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020". MMWR. Recommendations and Reports 69, n.º 9 (25 de setembro de 2020): 1–41. http://dx.doi.org/10.15585/mmwr.rr6909a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Smith, Jean C. "Immunization Policy Development in the United States: The Role of the Advisory Committee on Immunization Practices". Annals of Internal Medicine 150, n.º 1 (6 de janeiro de 2009): 45. http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00009.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Foster, Stephan L., e Michael D. Hogue. "Advisory Committee on Immunization Practices: Working to Improve Vaccine Use in the United States". Journal of the American Pharmacists Association 45, n.º 3 (maio de 2005): 408–11. http://dx.doi.org/10.1331/1544345054003831.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Gopal, Srirupa, Kathryn Edwards, Buddy Creech e Joern-Hendrik Weitkamp. "Variability in Immunization Practices for Preterm Infants". American Journal of Perinatology 35, n.º 14 (8 de junho de 2018): 1394–98. http://dx.doi.org/10.1055/s-0038-1660453.

Texto completo da fonte

Resumo:

Introduction The Advisory Committee on Immunization Practices and the American Academy of Pediatrics (AAP) recommend the same immunization schedule for preterm and term infants. However, significant delays in vaccination of premature infants have been reported. Objective The objective of this study was to assess the variability of immunization practices in preterm infants. Study Design We conducted an online survey of 2,443 neonatologists in the United States, who are members of the Section for Neonatal-Perinatal Medicine of the AAP. Questions were targeted at immunization practices in the neonatal intensive care unit (NICU). Results Of the 420 responses (17%) received, 55% of providers administer the first vaccine at >2-month chronological age. Most providers (83%) surveyed reported delaying vaccines in the setting of clinical illness. Sixty percent reported increasing frequency of apnea–bradycardia events following immunization. More than half administer the initial vaccines over several days despite lack of supporting data. Reported considerations in delaying or spreading out 2-month vaccines were clinical instability, provider preference, lower gestational age, and lower birth weight. Conclusion This survey substantiates the variability of immunizations practices in the NICU and identifies reasons for this variability. Future studies should inform better practice guidance for immunization of preterm NICU patients based on vaccine safety and effectiveness.

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Judelsohn, Richard. "Changing the US Polio Immunization Schedule Would Be Bad Public Health Policy". Pediatrics 98, n.º 1 (1 de julho de 1996): 115–16. http://dx.doi.org/10.1542/peds.98.1.115.

Texto completo da fonte

Resumo:

Last October, a 10-member advisory committee to the United States (US) Centers for Disease Control and Prevention (CDC) voted to change the US government's well-established polio immunization policy. The current polio immunization schedule, consisting of a regimen of four doses of oral poliovaccine (OPV), is widely credited with effectively eradicating polio in the US and the western hemisphere. In fact, the last naturally occurring case of polio occurred in the US in 1979 and in the western hemisphere in 1991. Because OPV contains a live but weakened virus, it has, on very rare occasions, been associated with paralytic polio. In the hope of preventing some of the 8 to 10 cases of vaccine-associated paralytic poliomyelitis (VAPP) diagnosed each year, the CDC's Advisory Committee on Immunization Practices (ACIP) has recommended a combined immunization schedule of two doses of inactivated polio virus (IPV), which is delivered by injection, followed by two doses of OPV.

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Wood, D. L., e P. A. Brunell. "Measles control in the United States: problems of the past and challenges for the future." Clinical Microbiology Reviews 8, n.º 2 (abril de 1995): 260–67. http://dx.doi.org/10.1128/cmr.8.2.260.

Texto completo da fonte

Resumo:

Elimination of indigenous measles from the United States has been a public priority since 1978. To assess the progress made toward this goal, we review the epidemiology of measles from 1963 to the present. From the 1970s through early into the recent measles epidemic, the majority of measles cases were in highly vaccinated, school-age children. This was due primarily to a 1 to 5% primary measles-mumps-rubella vaccine failure rate and nonrandom mixing patterns among school-age populations. To eliminate susceptible individuals in the school-age populations, a second dose of measles vaccine is now recommended between 5 and 6 years or 11 and 12 years by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Later in the epidemic, measles cases surged among unimmunized preschool children, especially among the poor in inner-city areas. Immunization rates have been documented to be low among preschool populations because of missed opportunities to administer vaccines at all health visits and barriers to access to immunizations. To raise immunization rates, the age for the first measles-mumps-rubella immunization was lowered to 12 to 15 months of age, federal immunization funding has increased, and new standards for immunization delivery have been developed and promulgated.

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Choi, Mary J., Caitlin M. Cossaboom, Amy N. Whitesell, Jonathan W. Dyal, Allison Joyce, Rebecca L. Morgan, Doug Campos-Outcalt et al. "Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020". MMWR. Recommendations and Reports 70, n.º 1 (8 de janeiro de 2021): 1–12. http://dx.doi.org/10.15585/mmwr.rr.7001a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Choi, Mary J., Caitlin M. Cossaboom, Amy N. Whitesell, Jonathan W. Dyal, Allison Joyce, Rebecca L. Morgan, Doug Campos-Outcalt et al. "Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020". MMWR. Recommendations and Reports 70, n.º 1 (8 de janeiro de 2021): 1–12. http://dx.doi.org/10.15585/mmwr.rr7001a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Hills, Susan L., Katherine A. Poehling, Wilbur H. Chen e J. Erin Staples. "Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023". MMWR. Recommendations and Reports 72, n.º 5 (10 de novembro de 2023): 1–29. http://dx.doi.org/10.15585/mmwr.rr7205a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Freedman, Mark S., Kevin Ault e Henry Bernstein. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021". MMWR. Morbidity and Mortality Weekly Report 70, n.º 6 (12 de fevereiro de 2021): 193–96. http://dx.doi.org/10.15585/mmwr.mm7006a2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Bridges, Carolyn B., e Tamera Coyne-Beasley. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2014*". Annals of Internal Medicine 160, n.º 3 (4 de fevereiro de 2014): 190–97. http://dx.doi.org/10.7326/m13-2826.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Kim, David K., Carolyn B. Bridges e Kathleen H. Harriman. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2015*". Annals of Internal Medicine 162, n.º 3 (3 de fevereiro de 2015): 214. http://dx.doi.org/10.7326/m14-2755.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Kim, David K., Carolyn B. Bridges e Kathleen H. Harriman. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2016*". Annals of Internal Medicine 164, n.º 3 (2 de fevereiro de 2016): 184. http://dx.doi.org/10.7326/m15-3005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Murthy, Neil, A. Patricia Wodi, Henry Bernstein, Veronica McNally, Sybil Cineas e Kevin Ault. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022". MMWR. Morbidity and Mortality Weekly Report 71, n.º 7 (18 de fevereiro de 2022): 229–33. http://dx.doi.org/10.15585/mmwr.mm7107a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Robinson, Candice L. "Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016". MMWR. Morbidity and Mortality Weekly Report 65, n.º 4 (5 de fevereiro de 2016): 86–87. http://dx.doi.org/10.15585/mmwr.mm6504a4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Robinson, Candice L., e ACIP Child. "Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016". MMWR. Morbidity and Mortality Weekly Report 65, n.º 4 (2 de fevereiro de 2016): 1–2. http://dx.doi.org/10.15585/mmwr.mm6504a4er.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Kim, David K., Carolyn B. Bridges e Kathleen H. Harriman. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016". MMWR. Morbidity and Mortality Weekly Report 65, n.º 4 (5 de fevereiro de 2016): 88–90. http://dx.doi.org/10.15585/mmwr.mm6504a5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Kim, David K., Carolyn B. Bridges e Kathleen H. Harriman. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016". MMWR. Morbidity and Mortality Weekly Report 65, n.º 4 (2 de fevereiro de 2016): 1–3. http://dx.doi.org/10.15585/mmwr.mm6504a5er.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Kim, David K., Laura E. Riley, Kathleen H. Harriman, Paul Hunter e Carolyn B. Bridges. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017". MMWR. Morbidity and Mortality Weekly Report 66, n.º 5 (10 de fevereiro de 2017): 136–38. http://dx.doi.org/10.15585/mmwr.mm6605e2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Kim, David K., Laura E. Riley e Paul Hunter. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018". MMWR. Morbidity and Mortality Weekly Report 67, n.º 5 (9 de fevereiro de 2018): 158–60. http://dx.doi.org/10.15585/mmwr.mm6705e3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Kim, David K., e Paul Hunter. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019". MMWR. Morbidity and Mortality Weekly Report 68, n.º 5 (8 de fevereiro de 2019): 115–18. http://dx.doi.org/10.15585/mmwr.mm6805a5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Freedman, Mark S., Paul Hunter, Kevin Ault e Andrew Kroger. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020". MMWR. Morbidity and Mortality Weekly Report 69, n.º 5 (7 de fevereiro de 2020): 133–35. http://dx.doi.org/10.15585/mmwr.mm6905a4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Robinson, C. L. "Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years-United States, 2016". American Journal of Transplantation 16, n.º 6 (20 de maio de 2016): 1928–29. http://dx.doi.org/10.1111/ajt.13858.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Kim, D. K., C. B. Bridges e K. H. Harriman. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2016". American Journal of Transplantation 16, n.º 6 (20 de maio de 2016): 1930–32. http://dx.doi.org/10.1111/ajt.13877.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Kim, D. K., L. E. Riley, K. H. Harriman, P. Hunter e C. B. Bridges. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2017". American Journal of Transplantation 17, n.º 4 (30 de março de 2017): 1132–35. http://dx.doi.org/10.1111/ajt.14244.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Kim, David K., e Paul Hunter. "Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2019". American Journal of Transplantation 19, n.º 4 (25 de março de 2019): 1232–35. http://dx.doi.org/10.1111/ajt.15336.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Murthy, Neil, A. Patricia Wodi, Veronica McNally, Sybil Cineas e Kevin Ault. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023". MMWR. Morbidity and Mortality Weekly Report 72, n.º 6 (10 de fevereiro de 2023): 141–44. http://dx.doi.org/10.15585/mmwr.mm7206a2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Murthy, Neil, A. Patricia Wodi, Veronica V. McNally, Matthew F. Daley e Sybil Cineas. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024". MMWR. Morbidity and Mortality Weekly Report 73, n.º 1 (11 de janeiro de 2024): 11–15. http://dx.doi.org/10.15585/mmwr.mm7301a3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Krow-Lucal, Elisabeth, Mona Marin, Leah Shepersky, Lynn Bahta, Jamie Loehr e Kathleen Dooling. "Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022". MMWR. Morbidity and Mortality Weekly Report 71, n.º 46 (18 de novembro de 2022): 1465–70. http://dx.doi.org/10.15585/mmwr.mm7146a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Bednarczyk, Robert A., Mallory K. Ellingson e Saad B. Omer. "Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data". Journal of Infectious Diseases 220, n.º 5 (17 de janeiro de 2019): 730–34. http://dx.doi.org/10.1093/infdis/jiy682.

Texto completo da fonte

Resumo:

Abstract Human papillomavirus (HPV) vaccination is suboptimally used in the United States. Vaccination before the 13th birthday is recommended by the Advisory Committee on Immunization Practices and vaccination before the 15th birthday requires only 2 doses. We estimated the proportion of adolescents up to date for HPV vaccine using provider-verified vaccination data from the 2016 National Immunization Survey-Teen. Only 16% of US adolescents completed HPV vaccination before turning 13, and 35% completed HPV vaccination before turning 15. With sexual activity initiation increasing throughout adolescence and higher immunogenicity for younger vaccinees, vaccination before the 13th birthday can provide better protection against HPV-related cancers.

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

CHIRICO, GAETANO, CESARE BELLONI, ANTONELLA GASPARONI, ROSA MARIA CERBO, GIORGIO RONDINI, CATHERINE KLERSY, PAOLO ORSOLINI e GAETANO FILICE. "Hepatitis B Immunization in Infants of Hepatitis B Surface Antigen-Negative Mothers". Pediatrics 92, n.º 5 (1 de novembro de 1993): 717–19. http://dx.doi.org/10.1542/peds.92.5.717.

Texto completo da fonte

Resumo:

The American Academy of Pediatrics (AAP) Committee on Infectious Diseases and the Immunization Practices Advisory Committee of the Centers for Disease Control have recently pointed out that the selective strategy of immunization against hepatitis B virus (HBV) of high-risk populations has not resulted in the limitation of the diffusion of the disease. In fact, in spite of vaccine availability for more than 10 years, about 200 000 to 300 000 new cases of infection occur in the United States each year. Therefore, the AAP recommended the "universal hepatitis B immunization" strategy as a means to control the disease.1,2 In Italy, where about 400 000 new cases of infection are expected each year, the vaccination has been extended to all newborns, regardless of mother's serologic status (and, for the first 12 years, to all 12-year-old adolescents), with a law promulgated in May 1991.

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Wodi, A. Patricia, Kevin Ault, Paul Hunter, Veronica McNally, Peter G. Szilagyi e Henry Bernstein. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021". MMWR. Morbidity and Mortality Weekly Report 70, n.º 6 (12 de fevereiro de 2021): 189–92. http://dx.doi.org/10.15585/mmwr.mm7006a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Wodi, A. Patricia, Neil Murthy, Henry Bernstein, Veronica McNally, Sybil Cineas e Kevin Ault. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022". MMWR. Morbidity and Mortality Weekly Report 71, n.º 7 (18 de fevereiro de 2022): 234–37. http://dx.doi.org/10.15585/mmwr.mm7107a2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Robinson, Candice L., José R. Romero, Allison Kempe e Cynthia Pellegrini. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017". MMWR. Morbidity and Mortality Weekly Report 66, n.º 5 (10 de fevereiro de 2017): 134–35. http://dx.doi.org/10.15585/mmwr.mm6605e1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Robinson, Candice L., José R. Romero, Allison Kempe, Cynthia Pellegrini e Peter Szilagyi. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2018". MMWR. Morbidity and Mortality Weekly Report 67, n.º 5 (9 de fevereiro de 2018): 156–57. http://dx.doi.org/10.15585/mmwr.mm6705e2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Robinson, Candice L., Henry Bernstein, José R. Romero e Peter Szilagyi. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019". MMWR. Morbidity and Mortality Weekly Report 68, n.º 5 (8 de fevereiro de 2019): 112–14. http://dx.doi.org/10.15585/mmwr.mm6805a4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Robinson, Candice L., Henry Bernstein, Katherine Poehling, José R. Romero e Peter Szilagyi. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020". MMWR. Morbidity and Mortality Weekly Report 69, n.º 5 (7 de fevereiro de 2020): 130–32. http://dx.doi.org/10.15585/mmwr.mm6905a3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Robinson, C. L., J. R. Romero, A. Kempe e C. Pellegrini. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2017". American Journal of Transplantation 17, n.º 4 (30 de março de 2017): 1136–38. http://dx.doi.org/10.1111/ajt.14245.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Robinson, Candice L., Henry Bernstein, José R. Romero e Peter Szilagyi. "Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger — United States, 2019". American Journal of Transplantation 19, n.º 4 (25 de março de 2019): 1229–31. http://dx.doi.org/10.1111/ajt.15335.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Wodi, A. Patricia, Neil Murthy, Veronica McNally, Sybil Cineas e Kevin Ault. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023". MMWR. Morbidity and Mortality Weekly Report 72, n.º 6 (10 de fevereiro de 2023): 137–40. http://dx.doi.org/10.15585/mmwr.mm7206a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Wodi, A. Patricia, Neil Murthy, Veronica V. McNally, Matthew F. Daley e Sybil Cineas. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024". MMWR. Morbidity and Mortality Weekly Report 73, n.º 1 (11 de janeiro de 2024): 6–10. http://dx.doi.org/10.15585/mmwr.mm7301a2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Bower, William A., Jarad Schiffer, Robert L. Atmar, Wendy A. Keitel, Arthur M. Friedlander, Lindy Liu, Yon Yu, David S. Stephens, Conrad P. Quinn e Katherine Hendricks. "Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019". MMWR. Recommendations and Reports 68, n.º 4 (13 de dezembro de 2019): 1–14. http://dx.doi.org/10.15585/mmwr.rr6804a1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Pike, Jamison, Andrew J. Leidner, Jessica R. MacNeil e Amanda C. Cohn. "Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012–2016". Vaccine 37, n.º 1 (janeiro de 2019): 7–10. http://dx.doi.org/10.1016/j.vaccine.2018.11.055.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!